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Abstract
Background: Observational evidence suggests that cigarette pack size – the number of cigarettes in a single pack
– is associated with consumption but experimental evidence of a causal relationship is lacking. The tobacco
industry is introducing increasingly large packs, in the absence of maximum cigarette pack size regulation. In
Australia, the minimum pack size is 20 but packs of up to 50 cigarettes are available. We aimed to estimate the
impact on smoking of reducing cigarette pack sizes from ≥25 to 20 cigarettes per pack.
Method: A two-stage adaptive parallel group RCT in which Australian smokers who usually purchase packs
containing ≥25 cigarettes were randomised to use only packs containing either 20 (intervention) or their usual
packs (control) for four weeks. The primary outcome, the average number of cigarettes smoked per day, was
measured through collecting all finished cigarette packs, labelled with the number of cigarettes participants
smoked. An interim sample size re-estimation was used to evaluate the possibility of detecting a meaningful
difference in the primary outcome.
Results: The interim analysis, conducted when 124 participants had been randomised, suggested 1122 additional
participants needed to be randomised for sufficient power to detect a meaningful effect. This exceeded pre-
specified criteria for feasible recruitment, and data collection was terminated accordingly. Analysis of complete data
(n = 79) indicated that the mean cigarettes smoked per day was 15.9 (SD = 8.5) in the intervention arm and 16.8
(SD = 6.7) among controls (difference − 0.9: 95%CI = − 4.3, 2.6).
Conclusion: It remains unclear whether reducing cigarette pack sizes from ≥25 to 20 cigarettes reduces cigarette
consumption. Importantly, the results of this study provide no evidence that capping cigarette pack sizes would be
ineffective at reducing smoking. The limitations identified in this study can inform a more efficient RCT, which is
urgently required to address the dearth of experimental evidence on the impact of large cigarette pack sizes on
smoking.
Trial registration: https://doi.org/10.1186/ISRCTN34202533
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Background
Despite progress in global tobacco control [1], smoking
remains one of the largest risk factors for disease glo-
bally [2] and a major cause of the gap in healthy life ex-
pectancy between the richest and poorest [3]. It has
been argued that cigarette pack size – the number of
cigarettes in a single pack –should be subjected to in-
creased regulation [4].
There is variation between countries in the range of
pack sizes available. A minimum of 20 cigarettes per
pack has been imposed by many countries (e.g., the
European Union Tobacco Products Directive (2014/40/
EU)) in order to maintain the upfront cost of cigarettes,
particularly targeting affordability for young people [5].
However, the tobacco industry is introducing larger pack
sizes to the market in response to new tobacco control
policies [5–7]. In Australia for example, packs of 20, 21,
22, 23, 25, 26, 30, 35, 40, 43 and 50 are all currently
available.
Robust experimental evidence suggests that larger por-
tions, packages and tableware increase food consump-
tion [8]. Cigarette pack size is also associated with
numbers of cigarettes smoked. A large survey of Austra-
lian smokers found that self-reported cigarettes per day
was positively associated with pack size [9]. Small packs
are used by some smokers as a method of self-regulating
consumption [10]. Tobacco industry documents reveal
that cigarette brands were released in packs of 25 rather
than 20 in an effort to reverse declines in sales by in-
creasing daily consumption [11]. However, experimental
evidence for a causal relationship between pack size and
consumption is lacking.
If larger packs increase smoking, then introducing a
cap on cigarette pack size could be an effective tobacco
control measure to reduce smoking and associated
health harms. There is broadly, if not exactly, a linear re-
lationship between number of cigarettes smoked and
harm caused by smoking [12, 13]. Smoking fewer ciga-
rettes per day increases the likelihood of quit attempts
[14] and eventual cessation [15], and is recommended in
the UK harm reduction guidelines issued by the National
Institute for Health and Care Excellence [16]. A Mendel-
ian randomisation study suggested that smoking one
fewer cigarette per day increases the odds of cessation
by 9% [17]. The impact of reducing smoking at a popu-
lation level can be estimated by conservatively assuming
a 5% increase in the odds of cessation for each fewer
cigarette smoked per day. In Australia for example, a re-
duction of two cigarettes per day is estimated to reduce
smoking prevalence by 0.3% over one year and thereby
increase the number of ex-smokers by 6367 a year [4].
Although the size of this policy impact may not be
maintained beyond its initial introduction, regulation
that prevents the introduction of larger pack sizes could
still play an important role in maintaining global de-
clines in smoking prevalence by preventing smokers
from switching to larger pack sizes (if this is an outcome
which discourages smoking cessation).
In sum, the direct influence of cigarette pack size on
smoking while plausible and potentially consequential is
currently uncertain. Our study aimed to estimate the im-
pact on cigarette consumption of a policy that caps
cigarette pack sizes at 20 in jurisdictions where this is
currently also the minimum pack size. We did this by
asking Australian smokers who usually smoke from
cigarette pack sizes of ≥25 cigarettes to smoke from
packs of 20 cigarettes.
We hypothesised that smokers using packs of 20 ciga-
rettes would smoke fewer cigarettes per day than would
smokers using packs of ≥25 cigarettes. A pilot study –
described in Additional File 1 – was conducted to in-
form key parameters of the present two-stage adaptive
randomised controlled trial (RCT).
Methods
Design
This was a two-stage adaptive parallel group RCT with a
planned sample size re-estimation conducted at an in-
terim stage of data collection, also known as an internal
pilot design. This design was selected because the esti-
mate of within-arm standard deviation (SD) from the ex-
ternal pilot study had a wide confidence interval and the
interim analysis would allow for a more accurate estima-
tion of the SD as a basis for assessing whether the ex-
pected effect size could be feasibly demonstrated.
Adaptive trials can make the most efficient use of re-
sources [18] by potentially allowing conclusions to be
reached more quickly, and requiring smaller sample
sizes on average than traditional trial designs, or avoid-
ing unnecessary use of resources conducting underpow-
ered trials.
A pre-specified criterion was established to terminate
the trial if the sample size re-estimation indicated that
more than 250 participants would need to be rando-
mised in order to detect the expected effect. Randomis-
ing more than 250 participants was not considered
feasible within the available resources.
Appendix 1 provides further information on design de-
cisions and accessing trial registration documents.
Intervention
Participants were randomised to one of two study arms.
Participants in the control arm were instructed to con-
tinue smoking their usual brand variant of cigarettes in
their usual pack size (25 cigarettes or more). Participants
in the intervention arm were instructed to purchase
their usual brand variant of cigarettes in pack sizes of
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20 cigarettes only. Data collection took place over a
period of four weeks.
Setting
The study took place in Australia, nationwide; data were
collected via telephone and post.
Sample
Australian smokers who smoke at least five cigarettes per
day and typically purchase pack sizes of ≥25 cigarettes (see
Appendix 2 for all inclusion and exclusion criteria) were re-
cruited by a research agency in Melbourne (Roy Morgan:
https://www.roymorgan.com). Data collection took place
between October 2018 and January 2019.
Participants were remunerated up to AUD$240 for
their time. Participants allocated to the intervention
were also reimbursed for the average additional cost in-
curred from purchasing the same number of cigarettes
in smaller pack sizes than usual.
Sample size
An initial sample size calculation used the estimate of
the within-arm SD of cigarettes per day from a pilot
study (5.1 (95% CI [3.7, 8.2]: Additional File 1), which in-
dicated that a sample size of 206 participants would give
80% power at the 5% significance level and a two-sided
test to detect a difference of two cigarettes per day. This
effect size was selected for importance at a population-
level (see Introduction), and plausibility.
Sample size was re-estimated during the interim ana-
lysis stage. Participants were recruited in weekly batches;
therefore, the analysis was planned for the first week
after at least 50 participants had provided outcome data,
which was considered sufficient [19, 20].
Randomisation
A simple randomisation sequence was generated by a se-
nior statistician (RM) not involved with recruitment or
data collection. The random number list was given to a
researcher at the research agency who was not involved
in enrolling participants. Participants’ allocation to con-
dition was concealed until after enrolment and comple-
tion of the baseline phase (see below). Participants were
blinded to the study hypothesis. The analyst completing
the data analysis (KDL) was blinded to allocation.
Measures
Primary outcome
The average number of cigarettes smoked per day. The
total number of cigarettes smoked over the four-week
study period was measured using information partici-
pants provided on labels attached to each cigarette pack
they smoked during the study (see Materials below). Par-
ticipants sent their labelled cigarette packs to the
research agency at the end of each week. For each par-
ticipant, the total number of cigarettes smoked over the
four-week study period was divided by 28.
Secondary outcomes
Heaviness of smoking, motivation to stop smoking and
autonomy over smoking were measured at the end of
the study, via a telephone survey, using the following
scales:
i. Heaviness of Smoking Index (HSI): a two-item meas-
ure of the number of cigarettes smoked per day and time
to first cigarette [20].
ii. Motivation to Stop Scale (MTSS): a single-item
measure [21] with responses to the question: Which of
the following describes you? Responses range from 1, I
don’t want to stop smoking to 7, I REALLY want to stop
smoking and intend to in the next month.
iii. Autonomy Over Smoking Scale (AUTOS): a 12-
item measure of tobacco dependence [22, 23].
Baseline measures
Age and gender were recorded at recruitment. Socioeco-
nomic status was measured using the Australian index
of Relative Socio-Economic Advantage and Disadvantage
(SEIFA, 24) which reflects a combination of education
level, income and occupation of respondent. Scores (out
of 60) for each of these three categories were combined
and summarised in population quintiles ranging from
the first quintile– lowest socioeconomic status (SES) –
to the fifth – highest SES [24]. The HSI, MTSS and
AUTOS were also measured at recruitment.
Materials
Cigarette pack labels
A set of white, green and red adhesive labels (5.5 × 6.5
cm) were provided to participants. They were asked to
attach a label to each cigarette pack smoked during the
four-week study period.
White labels had space for participants to fill in the
following information: date pack started, date pack fin-
ished, number of cigarettes smoked from the pack, num-
ber of cigarettes given away from the pack, and number
of cigarettes smoked from another pack (e.g., given by a
friend) during the stated dates. The green labels were for
the first cigarette pack used at the beginning of the study
and additionally had space for participants to record
how many cigarettes were in the pack, which may have
already been open. The red labels were for the final
cigarette pack used at the end of the study, which may
have been unfinished, and contained an additional field
for the number of cigarettes that remained.
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Instruction packs
Printed instructions were posted to participants along
with a set of labels, return slips and four pre-paid return
envelopes for participants to post their finished cigarette
packs at the end of each week.
Procedure
The study was presented to participants as investigating
how cigarette pack size affects the perception of health
warnings to avoid participants focusing on their smoking
in relation to pack size. Participants were asked to rate
health warning effectiveness on the pack labels.
After providing informed consent via an online form,
participants completed a one-week baseline phase that
aimed to familiarise them with the study procedures.
Participants were sent one pre-paid envelope in which
they were asked to return date-stamped receipts for
cigarette packs purchased over the baseline week.
Participants who successfully completed the baseline
week were randomly allocated to one of the two study
arms and sent an instruction pack by post. Participants
were instructed to smoke their regular brand variant of
cigarettes from only i. their usual pack size (≥25), or ii.
from pack sizes of 20, according to their allocated study
arm for the following four-week study period. Partici-
pants attached labels to each cigarette pack they fin-
ished, filled in the required information and posted
them back to the research agency at the end of each
week. In the first week only, participants were also asked
to return date-stamped receipts for cigarettes purchased
that week. These were used to calculate the reimburse-
ment for participants in the intervention condition in
cases where purchasing smaller packs incurred a greater
cost per cigarette than usual.
Text and telephone call reminders were sent to partici-
pants during the study to maximise adherence to the
intervention.
A telephone interview was conducted within two
weeks of the research agency’s receipt of the final enve-
lope. The true study aim was disclosed to participants
during the final telephone debriefing.
Data analysis
Sample size re-estimation
All analyses were conducted by a senior statistician
(MP) and analyst (KDL) who were not involved in data
collection and were blinded to allocation. The sample
size re-estimation procedure was conducted using R
statistical software (v3.4) [25]. The mean and SD were
calculated for each study arm along with the difference
in means with 95% confidence intervals (CIs) and the
precise p-value.
The remainder of the analyses were conducted in
SPSS 24.
Sample characteristics
Descriptive statistics were calculated for demographic
and smoking characteristics of participants in each study
arm.
Primary outcome
A full analysis of all outcome variables was conducted.
All imputations for missing data, and assumptions con-
cerning inconsistent responses on cigarette pack labels
were made prior to analyses (Additional File 2).
The primary analysis was a modified intention-to-treat
analysis in which data from participants were included
in the study arm to which they were allocated, excluding
participants who did not provide complete data. The
comparison of the primary outcome between study arms
was made by estimating the difference in means using
an independent samples t-test. A secondary analysis of
the primary outcome was carried out using analyses of
covariance (ANCOVA) adjusting for the pack sizes par-
ticipants reported typically smoking from at recruitment.
A per-protocol analysis was also conducted for the pri-
mary outcome, which included only those participants
who adhered to instructions by smoking from cigarettes
in the instructed pack size. Participants were deemed to
be adherent if at least 90% of the cigarette packs they
used during the study were of the correct size (excluding
packs already had open at the start of the study). The
per-protocol analysis was of interest, given our aim of
assessing the actual effect of a policy to introduce a max-
imum size of cigarette packs rather than just asking
people to smoke from smaller packs.
Secondary outcomes
Differences between study arms in the means of the sec-
ondary outcomes were estimated using ANCOVA where




Of the 336 smokers meeting the eligibility criteria, 187
(51.1%) consented to take part in the study. 124 partici-
pants completed the baseline week and were allocated to
one of the study arms (Fig. 1).
Of the 124 randomised participants, 79 (64%) completed
the study. All demographic characteristics were compar-
able between participants who were excluded and those
who completed the study (Table 1). The mean age of in-
cluded participants was 54.6 years (SD = 12.9). Participants
were mostly women (57%), had a median education level
of 9, indicating they had had some university or college of
Advanced Education training, (IQR = 5–12) and mean so-
cioeconomic quintile of 3.1 (SD = 1.3) with 38% of
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participants in the top two fifths of socioeconomic advan-
tage for the Australian population.
Sample size re-estimation
The interim analysis took place in February 2019 when
124 participants had been randomised. Due to the need
to communicate a decision rapidly to the research
agency regarding recruitment, the interim analysis used
a dataset without imputations for incomplete informa-
tion.1 Of the 79 participants who finished the study, 61
had complete data available at this stage (28 in control
arm, 33 in intervention arm).
The pooled SD of the number of cigarettes smoked
per day was 7.4 (Bootstrap 95%CI = 4.8, 9.5). The mean
difference in the number of cigarettes smoked between
the intervention and control conditions was 1.85 (SD =
7.4, 95%CI = -2.1, 5.8): participants smoked an average of
16.4 cigarettes per day (SD = 6.1) in the control condition,
compared to 14.5 cigarettes per day (SD = 8.6) in the
intervention condition. The sample size re-estimation in-
dicated that 552 additional participants with complete
data would be needed for sufficient power to detect a re-
duction of two cigarettes per day. To account for attrition,
1122 participants would need to be randomised. This met
the pre-specified criterion to terminate the trial due to fu-
tility (i.e., more than 250 participants in total would need
to be randomised).
Fig. 1 CONSORT flow diagram
1In this dataset, dashes written by participants on their labels had been
erroneously entered as missing data.
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The analyses of the data following imputation for in-
complete information are reported below (n = 79). These
changes did not alter the conclusion of the interim ana-
lysis to stop the trial.
Primary outcome: average number of cigarettes smoked
per day
Primary analysis
Data from participants were included in the study arm
to which they were allocated in an intention-to-treat
analysis. There was no clear evidence of a difference in
the number of cigarettes smoked per day between the
study arms (Table 2). Participants in the intervention
arm (instructed to smoke from packs of 20 cigarettes)
smoked 15.9 cigarettes per day (SD = 8.5) while those in
the control arm (instructed to smoke from packs of ≥25
cigarettes) consumed 16.8 cigarettes per day (SD = 6.7).
The mean difference was − 0.9 cigarettes per day
(95%CI = -4.3, 2.6, SE = 1.7, t(77) = − 0.498, p = .62, d = −
0.11).
Secondary analysis
With adjustment for participants’ usual pack size re-
ported at baseline, the estimated means for the number
of cigarettes smoked per day for participants in the
intervention group and the control group were 15.9
(SD = 7.7) and 16.7 (SD = 7.7) respectively with a mean
difference of − 0.8 cigarettes per day (95%CI = − 4.3, 2.6,
SE = 1.7). Once again, there was no evidence for a differ-
ence between groups (t(76) = − 0.471, p = .64).
Per protocol analysis
Of the 40 participants with complete data allocated to
the intervention arm, 25 (63%) adhered to instructions
Table 1 Participant demographics and smoking characteristics (N = 124)
Packs of ≥25
(Analysed, n = 39)
Packs of 20




Male 15 (39) 19 (48) 21 (47)
Female 24 (62) 21 (52) 24 (53)
Age, mean (SD) 55 (13) 55 (13) 51 (14)
Education levela, mean (SD) 8 (3) 8 (3) 8 (3.2)
SEIFAb, mean (SD) 3.1 (1.3) 3.1 (1.3) 3 (1.2)
Number of cigarettes smoked per day, n (%)
Less than 10 4 (10) 4 (10) 2 (4)
11–20 5 (13) 3 (8) 6 (13)
21–30 26 (67) 20 (50) 27 (60)
More than 30 per day 4 (10) 13 (33) 10 (22)
Usual pack size, n (%)
25 9 (23) 9 (23) 0 (0)
26 2 (5) 4 (10) 9 (20)
30 8 (21) 10 (25) 3 (7)
40 18 (46) 14 (35) 12 (26)
50 2 (5) 2 (5) 20 (43)
60c 0 (0) 1 (3) 2 (4)
HSId, mean (SD) 2.9 (1.1) 3.1 (1.5) 3.1 (1.2)
MTSSe, mean (SD) 2.9 (1.1) 3.1 (1.2) 2.9 (1.3)
AUTOSf, mean (SD) 16.6 (7.7) 15.3 (8.0) 15.5 (7.6)
aEducation Level:1. Some Primary School; 2. Finished Primary School; 3. Some Secondary School; 4. Some Technical Or Commercial/ TAFE; 5. Passed School
Certificate / Passed 4th Form / Passed Intermediate / Year 10 Junior or Achievement certificate; 6. Passed 5th Form / Year 11 / Passed Leaving or Sub-senior
certificate; 7. Finished Technical School / Commercial College / TAFE (including trade certificate) / other certificate or apprenticeship; 8. Finished or now studying
for Matriculation, Higher School Certificate (H.S.C.), V.C.E., Year 12, or Senior Certificate; 9. Some University or some college of Advanced Education training; 10.
Diploma from College of Advanced Education or TAFE (Not Degree), Tertiary or Management Training (including Diploma other than University Degree); 11. Now
at University or College of Advanced Education; 12. Degree from University or College of Advanced Education; 13. Higher Degree or Higher Diploma (e.g.
Ph.D, Masters)
bSEIFA (Socio-Economic Indexes for Areas) (lowest 20% of areas given quintile number of 1)
cNote: Some participants recorded usual pack size as 60; however, this was clarified to be bundles of 2 × 30 packs
dHSI = Heaviness of Smoking Index (range 0–6)
eMTSS =Motivation to Stop Scale (range 1–7)
fAUTOS = Autonomy Over Smoking Scale (range 0–36)
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to smoke cigarettes from packs of 20 cigarettes. In the
control arm, 38 out of 39 (97%) adhered to instructions
to smoke cigarettes from only their usual pack sizes of
≥25 cigarettes.
When only data from the adherent participants (as de-
fined above) were analysed, there was no clear evidence
of a difference in the number of cigarettes smoked per
day between the study arms (t(61) = − 0.299, p = 0.77).
The mean number of cigarettes smoked by participants
in the intervention arm was 16.1 (SD = 4.3) and in the
control arm was 16.6 (SD = 6.7) with a mean difference
of − 0.5 cigarettes per day (95%CI = -4.2, 3.0).
Secondary outcomes
There was no clear evidence of a difference in post-
intervention scores of heaviness of smoking (mean dif-
ference = − 0.30, F(1,72) = 1.263, p = 0.27, motivation to
stop smoking (mean difference = − 0.46, F(1,72) = 2.012,
p = 0.16) or autonomy over smoking (mean difference =
− 0.25, F(1,72) = 0.042, p = 0.84) between study arms
with adjustment for the same measures taken at baseline
(Table 2).
Discussion
The observed difference in the number of cigarettes
smoked was in the hypothesised direction, with fewer
cigarettes smoked per day in the intervention arm (pack
sizes of 20 cigarettes) than the control arm (pack sizes of
≥25 cigarettes). However, the confidence intervals
around the mean difference include the possibility of an
effect in either direction. Similarly, no differences in
heaviness of smoking, motivation to stop smoking or au-
tonomy over smoking were detected.
Larger cigarette packs are being introduced across the
global market, prompting calls for the introduction of
regulation to cap cigarette pack sizes [4]. To our know-
ledge, this was the first experimental research to investi-
gate the effect of reducing pack sizes (from ≥25 to 20
cigarettes per pack) on tobacco consumption. The sam-
ple size re-estimation, afforded by the adaptive design,
indicated that the number of additional participants re-
quired to detect the expected effect was not considered
feasible within available resources, so the study was ter-
minated at that stage.
Strengths and limitations
The use of an adaptive design was a strength of the
study; ensuring optimal use of resources given a lack of
existing experimental evidence regarding an estimate of
the effect and an uncertain estimate of the standard de-
viation of the primary outcome [18]. Terminating the
study early prevented researcher time and participant ef-
fort from being spent completing a study that would
have been underpowered to detect the hypothesised
effect.
Several limitations contributed to the early termination
of the study. The variability in the primary outcome –
number of cigarettes smoked per day – was higher than
expected based on our earlier pilot study, leading to a
large sample size re-estimation in the interim analysis.
There are two possible factors contributing to this
higher variability. First, it is possible that the measure-
ment of the number of cigarettes smoked per day was
unreliable. We used a novel method of measurement
that required participants to label and return their empty
cigarette packs. This approach intended to address con-
cern regarding the accuracy of traditional methods;











minus Packs of 20)
95% CI p Cohen’s d
Number of cigarettes smoked per day
Primary analysisa 16.8 (6.7) 15.9 (8.5) −0.9 −4.3, 2.6 0.620 − 0.11
Secondary analysis* 16.7 (7.7) 15.9 (7.7) −0.8 −4.3, 2.6 0.639 −0.25
Per protocol analysis 16.6 (6.7) 16.1 (4.3) −0.5 −4.2, 3.0 0.766 −0.09
Smoking behaviour and attitudes (post-intervention)**
HSIb 3.1 (1.1) 2.8 (1.1) −0.30 − 0.82, 0.23 0.265 − 0.26
MTSSc 3.8 (1.4) 3.4 (1.4) −0.46 −1.10, 0.19 0.160 −0.33
AUTOSd 17.9 (5.2) 17.6 (5.2) −0.25 −2.67, 2.16 0.838 −0.05
*adjusted for pack size used at baseline, ** adjusted for same measures taken at baseline
aDue to deviations from normality in the primary and secondary outcomes, all analyses were repeated using a bootstrapping method. These produced similar results
bHSI = Heaviness of Smoking Index (range 0–6)
cMTSS =Motivation to Stop Scale (range 1–7)
dAUTOS = Autonomy Over Smoking Scale (range 0–36)
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smokers are known to under-report the number of ciga-
rettes they smoke by up to one-third when using survey
methods [26]. The labels used in our study required par-
ticipants to fill in non-mutually exclusive fields. Unfortu-
nately, this sometimes resulted in inconsistent responses
that were difficult to interpret (e.g. a label on a pack of
20 cigarettes suggesting that the participant had smoked
20 of these cigarettes themselves and given away five).
The full dataset is available (URL to be added if ac-
cepted) and includes details of the decisions made re-
garding interpretation of ambiguous responses (see also
Additional File 2).
Second, non-adherence to the intervention may have
also increased the variability in the primary outcome.
Only 63% of participants in the intervention arm com-
plied with the study procedures to purchase cigarettes in
pack sizes of 20, and instead continued to purchase in
larger pack sizes more than 10% of the time. This con-
trasts to the adherence rate of 97% in the control condi-
tion. This non-adherence is likely to have undermined
the effect of the intervention. Based on feedback from
participants after the study, a lack of availability of the
correct pack size in participants’ local shops is a possible
explanation for the high level of non-adherence. This
could be mitigated in a future study by ensuring prior to
randomisation that participants can purchase their
cigarette packs in their usual pack size (≥25 cigarettes)
and a pack size of 20. If more participants had been able
to adhere to the intervention, the per-protocol analysis
would have carried greater precision in estimating the
true impact of the pack size.
Smokers participating in the current study may not be
representative of all smokers due to participants self-
selecting and needing to be highly motivated to
complete the study procedures and to pay closer atten-
tion than usual to their smoking which may, inadvert-
ently, have increased their motivation to quit or cut
down. Importantly, the current study was designed to
detect a difference between randomised groups and so
these factors should not cause a bias of the effect esti-
mate as these factors will not affect the separate groups
differentially.
The study sample are older than the average population
of Australian daily smokers and older smokers generally
smoke more and use larger pack sizes. However, the sam-
ple was also mostly female and more highly educated than
the general population of Australian smokers and use of
larger pack sizes is greater among males and the low-SES
population [27], who also smoke more cigarettes per day
on average [28]. Those with higher levels of consumption
and who use larger pack sizes are expected to dispropor-
tionately benefit from a capping policy. Therefore, the re-
sults of the current study would likely substantially
underestimate the magnitude of potential reductions in
the total Australian population of smokers, and the poten-
tial prevention of escalation in consumption in countries
that do not currently have large (> 25) pack sizes.
Implications for research and policy
Considerable uncertainty remains regarding the true ef-
fect of capping cigarette pack sizes at 20 in jurisdictions
where this is currently the minimum pack size (i.e., man-
dating a single pack size of 20 cigarettes only). Given the
policy’s possible impact on smoking cessation, further
investigation is warranted to produce a reliable effect es-
timate and establish its potential to contribute to global
tobacco control measures [4]. Hoffman and colleagues
[29] warn against complacency in tobacco control,
highlighting the need for well-implemented, effective
policies. These lessons learned from the present study
could inform a more efficient RCT. A study with a
cross-over design, in which each participant takes part
in both study arms, is likely to have greater power to de-
tect an effect because within-person variation in
cigarette consumption is generally smaller than
between-person variation [30].
In this study we aimed to isolate the impact of pack
size from the impact of price by compensating partici-
pants for the increase in cost-per-stick they would ex-
perience as a result of purchasing cigarettes in a smaller
pack size. It is possible that a real-world cap on cigarette
pack sizes would help to maintain a high cost per stick
by reducing the opportunity for price-related promo-
tions by tobacco companies [4] which may further con-
tribute to the impact of the intervention.
Conclusion
It remains unclear whether capping cigarette pack sizes
at 20 in jurisdictions where this is currently the mini-
mum pack size reduces cigarette consumption. Import-
antly, the results of this study provides no evidence that
capping cigarette pack sizes would be ineffective at redu-
cing smoking. An adaptive design allowed the early ter-
mination of a study that would have been underpowered
to detect an effect. The limitations identified in this
study can inform a more efficient RCT. Given the poten-
tial impact of increasing pack sizes on tobacco consump-
tion, and the value of a policy to cap cigarette pack sizes
to contribute to reducing global smoking prevalence,
further research is urgently required to address the
dearth of experimental evidence in this area.
APPENDIX 1
OSF STUDY DOCUMENTS AND ISRCTN REGISTRATION
The following documents related to this study can be
found on the OSF: https://osf.io/g45zn/
01 Jun 2018 ‘Protocol Cig Pack Size_V1.0_31 May
2018.pdf’.
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18 Jan 2019 ‘Protocol Cig Pack Size V3.0
03.12.2018.pdf’.
18 Jan 2019 ‘A note on protocol V3.0.pdf’.
11 Jun 2019 ‘Detailed analysis plan for cig pack size_v4
190611.pdf’.
11 Jun 2019 ‘Appendix A. Missing data and inconsist-
ent responses 20190430.pdf’.
In June 2018, we planned to conduct a pilot study, to
inform a subsequent RCT, and we registered the proto-
col on the OSF prior to data collection (Protocol Cig
Pack Size_V1.0_31 May 2018.pdf, see https://osf.io/zt8dh
for dated registration).
The pilot study had aimed to recruit up to 70 partici-
pants in order to estimate the likely standard deviation
(SD) of the primary outcome, and the retention rate
among those recruited. Owing to a concern that the pool
of potential participants within the research agencies
panel for the main RCT would be diminished by this ex-
ternal pilot, a decision was made to terminate the pilot
study after 17 participants had been randomised and full
outcome data had been obtained from 14 participants.
We used these data to estimate the within-arm SD. Be-
cause the estimate had a wide confidence interval, we
opted to begin the main study with an adaptive design
(Chow & Chang, 2011). This involves an interim stage of
analysis to allow for a more accurate estimation of the
SD as a basis for assessing whether the expected effect
size can be feasibly demonstrated (A note on protocol
V3.0.pdf).
In January 2019, we uploaded a revised RCT protocol
(Protocol Cig Pack Size V3.0 03.12.2018′). The RCT, in-
cluding the hypothesis, was also registered on ISRCTN
(https://doi.org/10.1186/ISRCTN34202533), after data
had been collected but before the interim analysis took
place.
In June 2019, a full analysis plan of all outcomes was
uploaded prior to conducting data analysis (Detailed
analysis plan for cig pack size_v4 190,611.pdf, see
https://osf.io/xa7uz for dated registration).
APPENDIX 2
INCLUSION AND EXCLUSION CRITERIA
Inclusion criteria
i. Aged 18 and over.
ii. Smoke only factory-made cigarettes.
iii. Smoke 5 or more cigarettes a day on every day of
the week.
iv. Smoked at least 100 cigarettes in his or her lifetime.
v. Routinely purchase cigarettes in packs of 25 or
more.
vi. Use a brand variant in which cigarettes are available
in pack sizes of 20 as well as sizes of one or more of
the following: 25, 26, 30, 35, 40, 43 and/or 50.
vii. Use a brand that is stocked in a pack size of 20 by
at least one of the two major Australian
supermarkets in the month before recruitment.
viii.Live anywhere in Australia.
ix. Able to read and write sufficient English to
complete all study procedures.
x. Willing to collect and post one week of receipts of
cigarettes purchased at baseline.
xi. Willing to record on each cigarette pack dates
when the pack was opened and when finished.
xii. Willing to post weekly envelopes – on four
consecutive weeks - containing all empty packs of
cigarettes smoked in the preceding week with
completed forms.




ii. Intend to quit smoking in the next three months.
iii. Used e-cigarettes weekly over the past month, and
intend to continue.
iv. Smoke roll-your-own (RYO) cigarettes.
v. Normally transfer cigarettes into a case.
vi. Don’t usually buy their own cigarettes.
vii. Live in the same household as someone who has
enrolled in the study.
viii.Do not own a mobile phone or similar device with
the ability to send photos via a text or email
message.
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